This site is intended for healthcare professionals
Light microscopy of the internal lining of the urinary bladder; haematoxylin and eosin stain
Managing High-Risk NMIBC

Diagnosis: Making sense of multiple guidelines

Last updated: 13th Okt 2025
Published: 13th Aug 2025

Episode 2. “The philosophy of picking the right guideline lies in selecting the best from each group of guidelines,” says Morgan Rouprêt. In this episode, he and Ashish Kamat explore how clinicians navigate NMIBC guidelines, the emerging role of AI in decision-making, and the balance of evidence and real-world constraints to deliver equitable, personalized care across diverse healthcare settings. View transcript.

Chapters
00:00 Welcome and introductions
00:20 Choosing between guidelines
06:17 Gray zones within guidelines
09:36 Role of AI in clinical guideline use
13:14 Guidelines vs regional access gaps
17:52 Wrap-up

Read more about navigating multiple NMIBC guidelines.

 

Next episode

Return to episode list

 

Meet the guest speaker

Morgan Roupret, circle profile pictureMorgan Rouprêt, MD, PhD

Morgan Rouprêt is a Professor of Urology at AP-HP Sorbonne University and Pitié-Salpêtrière Hospital, Paris, France. He serves as Chair of the European Section of Onco-Urology (ESOU) and is Editor-in-Chief of European Urology Oncology.

Disclosures: Consulting and speaker engagements with Astellas, AstraZeneca, CG Oncology, Ferring, Intuitive Surgical, Janssen, MSD, Pfizer, and Roche.